drugset / Trial / NCT02627807

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

NCT02627807

Unknown 386 enrolled Sun Yat-sen University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare individualized clinical target volume (CTV) based on disease extension risk atlas and computer-aided delineation with traditional CTV in intensity modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC), in order to confirm the efficacy and safety.

Timeline

Start
2015-12
Primary completion
2020-12
Completion
2022-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Cisplatin Other / unclassified 75 mg/m2
Background Cisplatin Other / unclassified 80 mg/m2
Background Cisplatin Other / unclassified 100 mg/m2
Background Docetaxel Small molecule 75 mg/m2
Background Gemcitabine Small molecule 1000 mg/m2